Document:

2005 Directors Deferred Compensation Plan of Marshall & Ilsley Corp.

 Exhibit 4.4 
 2005 DIRECTORS DEFERRED COMPENSATION PLAN 
 OF 

MARSHALL & ILSLEY CORPORATION 
 as amended as of April 26, 2011 
 Recitals 

The purpose of the Plan is to allow the Company’s directors to defer all or a portion of their compensation for serving on the
Company’s Board of Directors. Such deferrals are deemed invested, at the directors’ elections, in either Common Shares (as defined below) or Treasury Bills (with the exception of restricted shares and restricted stock units which are
invested in Common Shares). At retirement from the Board of Directors of the Companies, deferrals are paid out over a period of time previously designated by each director, unless otherwise provided herein. 

Article I 

Definitions 
 “Account A” means a bookkeeping account being administered for the benefit of a Participant under Paragraph 3.1, below, and any sub-accounts thereof. 

“Account B” means a bookkeeping account being administered for the benefit of a Participant under Paragraph 3.2, below,
and any sub-accounts thereof. 
 “Account C” means a bookkeeping account being administered for the benefit of
a Participant under Paragraph 3.3, below, and any sub-accounts thereof. 
 “Administrator” means the person or
persons selected pursuant to Article VI, below, to control and manage the operation and administration of the Plan. 

“Affiliate” means any corporation or other entity which directly or indirectly controls, is controlled by, or under
common control with, the referenced entity. Control means the ability of the Company or any direct or indirect subsidiary of the Company to elect a majority of the Board of Directors of the corporation or other entity, or if there is no Board of
Directors, a majority of the body which governs the entity. 
 “Bank of Montreal” means Bank of Montreal, a
Schedule I Bank under the Bank Act (Canada). 
 “BMO Financial Corp.” means a wholly-owned subsidiary of Bank
of Montreal and successor to Marshall & Ilsley Corporation after the Merger. 

 “Change in Control” has the same meaning as in the Marshall &
Ilsley Corporation 2010 Equity Incentive Plan. 
 “Code” means the Internal Revenue Code of 1986, as amended.

 “Committee” means, prior to the Merger, the Compensation and Human Resources Committee of the Board of
Directors of the Company, or such other Committee as may be designated by the Board of Directors of the Company from time to time. After the Merger, the “Committee” means the Human Resources Committee of the Board of Directors of Bank of
Montreal, or such other Committee as may be designated by the Board of Directors of Bank of Montreal from time to time. 

“Common Shares” means the authorized and issued or unissued $1.00 par value common stock of Marshall & Ilsley
Corporation, which after the Merger shall refer to the common shares, without nominal or par value, of Bank of Montreal. 

“Companies” means, prior to the Separation Transaction, Marshall & Ilsley Corporation and any subsidiary
thereof. After the Separation Transaction and prior to the Merger, “Companies” means the publicly-traded corporation with the name Marshall & Ilsley Corporation, and all entities that are Affiliates thereof. After the Merger,
“Companies” means BMO Financial Corp. and all entities that are Affiliates thereof. 
 “Company”
means, prior to the Separation Transaction, Marshall & Ilsley Corporation, a Wisconsin corporation, or a successor thereof. After the Separation Transaction and prior to the Merger, the “Company” means the publicly-traded
corporation with the name Marshall & Ilsley Corporation. After the Merger, the “Company” means BMO Financial Corp. or any successor thereto. 
 “Compensation” means the annual retainer fees, Board meeting fees and committee meeting fees payable by the Companies to a Participant for a Plan Year. 

“Director” means any member of the Boards of Directors of the Companies who is not an employee of the Companies.

 “Distribution Election” means the election by a Participant, from time to time, to choose the method of
distribution of his deferrals, and any deemed investment increases or decreases attributable thereto. The methods of distribution contained in the form of Distribution Election can be changed from time to time at the discretion of the Administrator.

 “Fair Market Value” means the closing sale price of the Common Shares and/or the Fidelity Stock, as the
context requires, on the New York Stock Exchange as reported in the Midwest Edition of the Wall Street Journal or, with respect to the Common Shares after the Merger, on the Toronto Stock Exchange, for the applicable date; provided
that, if no sales of Common Shares or Fidelity Stock were made on said exchange on that date, “Fair Market Value” shall mean the closing sale price of the Common Shares or Fidelity Stock, as applicable, as reported for the next
succeeding day on which sales of Common Shares or Fidelity Stock are made on said exchange, or, failing any such sales, such other market price as the Committee may determine in conformity with pertinent law and regulations of the Treasury
Department. 

  
 2 

 “Fidelity” means Fidelity National Information Services, Inc., the
successor by merger to Metavante. 
 “Fidelity Stock” means the class of common stock of Fidelity traded on the
New York Stock Exchange, which is the class of common stock received in exchange for Metavante Stock in the merger of these entities. 
 “Investment Election” means the election by the Participant, from time to time, which designates the Participant’s investment choices. 

“Merger” means the transaction provided for in the Merger Agreement whereby Marshall & Ilsley Corporation will
merge with and into a wholly-owned subsidiary of Bank of Montreal as described in the Merger Agreement. 
 “Merger
Agreement” means the Agreement and Plan of Merger by and between Bank of Montreal and Marshall & Ilsley Corporation dated as of December 17, 2010. 
 “Metavante” means, after the Separation Transaction, the publicly-traded parent of the group of companies that included the Company’s former subsidiary, Metavante Corporation.

 “Metavante Stock” means the class of common stock of Metavante that was traded on the New York Stock
Exchange. 
 “Participant” means each member of or Board of Directors of the Companies who elects to
participate in the Plan for a Plan Year. 
 “Plan” means this 2005 Directors’ Deferred Compensation Plan
of Marshall & Ilsley Corporation, as the same hereafter may be amended from time to time. 
 “Plan
Year” means the 12-month period beginning on January 1 of any year and ending on December 31. 

“Restricted Shares” means an award of stock under a Company plan, which may contain transferability or forfeiture
provisions (including a requirement of future services), all as set forth in an award agreement. 
 “Restricted Stock
Units” means units held in a Participant’s Account C which are received upon a deferral of Restricted Shares or directly as a grant from the Company and have transferability or forfeiture provisions (which may include the requirement
of future services). Each Restricted Stock Unit represents one notional Common Share or one share of notional Fidelity Stock if the Restricted Stock Unit was previously a Restricted Stock Unit for notional Metavante Stock received as a result of the
Separation Transaction, which became a Restricted Stock Unit for shares of notional Fidelity Stock after the merger of Metavante with and into Fidelity. 

  
 3 

 “Separation from Service” has the same meaning as in Treas. Reg.
§1.409A-1(h)(2)(i) promulgated under Section 409A of the Code. 
 “Separation Transaction” means the
transaction whereby Metavante and the Company become separate publicly-traded companies. 
 “Trust” means the
Company’s Amended and Restated Deferred Compensation Trust III. 
 Article II 

Participation and Election of Accounts 
 2.1. Participation. Each Director may elect, in accordance with the election procedures prescribed by the Committee from time to time, to become a Participant in the Plan for a Plan Year and to
have all or a portion of his Compensation or Restricted Shares, if any, for such Plan Year deferred for his benefit under the Plan. In addition, a Director will become a Participant in the Plan if he is awarded Restricted Stock Units. In no event
may such deferral election be filed after the beginning of the Plan Year, except when a Director becomes eligible to participate in the Plan after the beginning of the Plan Year, in which event the Director will have thirty days from the date of
eligibility to make an election for Compensation or Restricted Shares, if any, earned after such date. 
 2.2. Election of
Accounts. At the time a Director elects to be a Participant for a Plan Year, he also may elect that any portion or all of his Compensation for the Plan Year which is deferred hereunder be allocated to his Account A or Account B. If no such
election is made, all of his Compensation deferred for the Plan Year shall be allocated to his Account B. Restricted Stock Units will be allocated to Account C. 
 2.3. Manner of Election. Any election pursuant to Paragraphs 2.1 or 2.2, above, shall be made in such manner as the Committee shall prescribe from time to time. If a Participant elects to have less
than all of his Compensation for a Plan Year deferred or elects that portions of his deferred Compensation be allocated to different Accounts, the election shall set forth the method for determining the amount to be so deferred or allocated.

 Article III 
 Administration of Accounts 
 3.1. Account A. 

(a) Amounts allocated to a Participant’s Account A shall be deemed to be invested in Common Shares on a monthly basis, and such
Participant’s Account A shall be deemed credited with the equivalent number of notional Common Shares (hereinafter referred to as “Credited Shares”) in the amount which would have been purchased on a common investment date, which

  
 4 

 
will typically be any of the first five business days of any month, determined in the sole discretion of an independent brokerage agent. In addition, to the extent Credited Shares are deemed
held, or shares of Fidelity Stock are deemed held, on the record date for any dividend, each Participant’s Account A shall be deemed credited with a number of additional Credited Shares or shares of Fidelity Stock resulting from the
reinvestment of dividends on a common investment date, which will be the date the dividend is paid in the case of dividends on Common Shares and any of the first five business days after the payment of the dividend, determined in the sole discretion
of an independent brokerage agent, in the case of shares of Fidelity Stock. 
 (b) In the event of any distribution with respect
to Common Shares or Fidelity Stock other than a cash dividend, such as a stock split, stock dividend or similar transaction, each Participant’s Account A shall be credited with a number of additional notional Credited Shares, notional
Fidelity Stock or other consideration as determined by the Committee in its sole discretion. In clarification of the foregoing, upon the occurrence of the Separation Transaction, the sub-accounts of a Participant’s Account A were deemed to
hold both Common Shares and Metavante Stock determined as if the Participant were a shareholder of the Company for the number of shares in the relevant sub-account of Account A immediately prior to the Separation Transaction. Upon the occurrence of
the merger of Metavante with and into Fidelity, the sub-accounts of a Participant’s Account A were deemed to hold both Common Shares and Fidelity Stock determined as if the Participant were a shareholder of Metavante for the number of
shares of Metavante Stock in the relevant sub-account of Account A immediately prior to such merger. 
 (c) In the event of
a Change in Control (such as the Merger) or a change in control of any other corporation whose stock is held in the sub-accounts of Account A, such sub-accounts of a Participant’s Account A shall be deemed credited with the same amount and type
of consideration which a shareholder of the Company would have received holding the same number of Common Shares or other corporation’s stock as are deemed to be held in the sub-accounts of the Participant’s Account A at the time of the
payment of the consideration. If there is a shareholder election as to the type of consideration received in a Change in Control, the sub-accounts of a Participant’s Account A will be deemed credited with consideration assuming that the
Participant elected the maximum amount of Common Shares which is available to electing shareholders, adjusted for any proration required because of oversubscription. Notwithstanding the foregoing, if cash is received in connection with a Change in
Control or other change in control, such cash will be credited to the relevant sub-accounts of Account B which have the same distribution options as the sub-accounts of Account A in which the applicable Common Shares deemed converted to cash were
previously held. 
 (d) Account A will be deemed denominated in whole and fractional Common Shares or shares of Fidelity
Stock. A Participant’s Account A shall be divided into the same number of sub-accounts as the number of alternatives contained in the Distribution Election from time to time. Deferrals for a Plan Year, and any dividends or shares associated
therewith, shall be deemed credited to a sub-account based on the Distribution Election for such Plan Year. 
 3.2. Account
B. Amounts allocated to a Participant’s Account B, pursuant to the election form provided to the Participant by the Company, shall be considered to be invested in U.S. 

  
 5 

 
Treasury Bills having a maturity of 13 weeks. Each Participant’s Account B shall be credited with the amount of interest which would have been earned during the applicable period if the
balance in a Participant’s Account B were invested in U.S. Treasury Bills with a maturity of 13 weeks. The rate of interest applied will be determined by the Committee or its designees from time to time in accordance with guidelines disclosed
to the Participants. A Participant’s Account B shall be divided into the same number of sub-accounts as the number of alternatives contained in the Distribution Election from time to time. Deferrals for a Plan Year, and any earnings
associated therewith, shall be deemed credited to a sub-account based on the Distribution Election for such Plan Year. 
 3.3
Account C. 
 (a) Restricted Stock Units shall be deemed to be allocated to a Participant’s Account C and shall be
considered to be invested in notional Credited Shares or after the Separation Transaction and the merger of Metavante with and into Fidelity, shares of Fidelity Stock, if applicable. In addition, to the extent notional Credited Shares or shares of
notional Fidelity Stock are deemed held on the record date for any dividend, each Participant’s Account C shall be deemed credited with a number of additional notional Credited Shares or shares of notional Fidelity Stock resulting from the
reinvestment of dividends on a common investment date, which will be the date the dividend is paid in the case of dividends on Common Shares and any of the first five business days after the payment of the dividend, determined in the sole discretion
of an independent brokerage agent, in the case of shares of Fidelity Stock. 
 (b) In the event of any distribution with respect
to notional Common Shares or shares of notional Fidelity Stock other than a cash dividend, such as a stock split, stock dividend or similar transaction, each Participant’s Account C shall be deemed credited with a number of additional
notional Credited Shares, shares of notional Fidelity Stock or other consideration as determined by the Committee in its sole discretion. In clarification of the foregoing, upon the occurrence of the Separation Transaction, the sub-accounts of a
Participant’s Account C were deemed to hold both Common Shares and Metavante Stock (including Restricted Stock Units) determined as if the Participant were a shareholder of the Company for the number of Common Shares in the relevant
sub-account of Account C immediately prior to the Separation Transaction. Upon the occurrence of the merger of Metavante with and into Fidelity, the sub-accounts of a Participant’s Account C were deemed to hold both Common Shares and
shares of Fidelity Stock (including Restricted Stock Units) determined as if the Participant were a shareholder of Metavante for the number of shares of Metavante Stock in the relevant sub-account of Account C immediately prior to such merger.

 (c) In the event of a Change in Control or a change in control of any other corporation whose stock is held in Account C, a
Participant’s Account C shall be deemed credited with the same amount and type of consideration which a shareholder of the Company would have received holding the same number of Common Shares or shares of such other corporation’s stock as
are held in the Participant’s Account C at the time of the payment of the consideration. If there is a shareholder election as to the type of consideration received in a Change in Control, a Participant’s Account C will be deemed
credited with consideration assuming that the Participant elected the maximum amount of stock which is available to 

  
 6 

 
electing shareholders, adjusted for any proration required because of oversubscription. Notwithstanding the foregoing, if cash is received in connection with a Change in Control or other change
in control, such cash will be credited to the relevant sub-accounts of Account B which have the same distribution options as the sub-accounts of Account A in which the applicable Common Shares deemed converted to cash were previously held.

 (d) Account C will be deemed denominated in whole and fractional shares. A Participant’s Account C shall be divided
into the same number of sub-accounts as the number of alternatives contained in the Distribution Election from time to time. Deferrals for a Plan Year, and any dividends or shares associated therewith, shall be deemed credited to a sub-account based
on the Distribution Election for such Plan Year. While any Restricted Stock Units that fail to vest will be forfeited, consistent with the treatment of Restricted Shares, any dividends credited as regards Restricted Stock Units shall not be
forfeited. 
 3.4. Investment Elections for Accounts A and C After the Separation Transaction and the Merger of Metavante and
Fidelity. 
 (a) The Participant may constructively sell any or all vested shares of Fidelity Stock by making a new Investment Election, no
later than 3 PM Central Time on the last business day of such month, setting forth the number of shares to be sold. The number of Common Shares deemed purchased will equal the number of Common Shares that could have been purchased by the
Trust with the proceeds recognized from the sale of such Fidelity Stock on the last business day of the applicable month, which Common Shares will then be credited to Account A or C which previously held the shares of Fidelity Stock that were sold.
Any transaction costs incurred by the Trust will reduce the proceeds available to be deemed invested in Common Shares. Notwithstanding the foregoing, if the Participant is subject to the Company’s insider trading policy, an Investment
Election under this Section 3.4(a) can only be made when the trading window is open, and will become irrevocable as to investments in notional Common Shares when the trading window closes, even if it is prior to the due date for the
election. 
 (b) A Participant may constructively sell any or all Restricted Stock Units of Fidelity Stock by making a new
Investment Election no later than 3 PM Central Time on the last business day of such month setting forth the number of shares underlying the Restricted Stock Units to be sold. The number of Common Shares deemed purchased will equal the number of
Common Shares that could have been purchased by the Trust with the proceeds recognized from the sale of such Fidelity Stock on the last business day of the applicable month, which notional Common Shares will then be deemed credited to Account A or C
which previously held the shares of Fidelity Stock that were deemed sold. Any transaction costs incurred by the Trust will reduce the proceeds available to be deemed invested in notional Common Shares. Any restrictions governing the Restricted Stock
Units of Fidelity Stock sold will govern the notional Common Shares deemed purchased with the proceeds of the deemed sale of such Fidelity Stock. Notwithstanding the foregoing, if the Participant is subject to the Company’s insider trading
policy, an Investment Election under this Section 3.4(b) can only be made when the trading window is open, and will become irrevocable as to investments in notional Common Shares when the trading window closes, even if it is prior to the due
date for the election. 

  
 7 

 (c) A Participant’s Accounts A and C shall reflect only the performance of Common
Shares and Fidelity Stock, if any, which is held in such Account A or C, and the Participant shall have no property right or security interest in any actual Common Shares or Fidelity Stock, which with respect to Fidelity Stock only, may be held by
the Trust to provide for the payment of benefits under this Plan. 
 3.5. Change of Accounts. Once amounts have been
allocated to Account A, Account B or Account C, these amounts must remain in Account A, B or C until such amounts are distributed to the Participant pursuant to Article IV hereof. Notwithstanding the foregoing, if cash is received in
connection with a Change in Control or other change in control, such cash will be automatically credited to Account B. Upon a Change in Control, the Company, the Administrator and any successors thereto may not change the investment choices
available to Participants hereunder without the consent of a majority of the holders of Account balances under the Plan. 
 3.6.
Nature of Account. The accounts established for each Participant hereunder and assets, if any, acquired by the Company or the Trust to measure a Participant’s benefits hereunder, shall not constitute or be treated for any reason as a
trust for, property of or a security interest for the benefit of, a Participant, his beneficiaries or any other person. Participant and the Company acknowledge that the Plan constitutes a promise by the Company to pay benefits to the Participants or
their beneficiaries, that Participants’ rights hereunder (by electing to defer Compensation hereunder) are limited to those of general unsecured creditors of the Company or the Affiliate where a Participant served as a director and that the
establishment of the Plan, acquisition of assets to measure Participant’s benefits hereunder or deferral of all or any portion of a Participants’ Compensation hereunder does not prevent any property of the Company, the Affiliate where a
Participant served as a director or the Trust from being subject to the right of all the Company’s creditors (or if the Participant did not serve as a director of the Company, the creditors of the Affiliate where a Participant served as a
director). The Company shall contribute all contributions hereunder to the Trust which will comply with the requirements of the Internal Revenue Service’s model trust, as described in Revenue Procedure 92-64. 

3.7 Maintenance of Accounts. To the extent not otherwise provided hereunder, the reconciliation of Accounts, and the computation
of the increases and decreases in the Accounts, shall be computed in the same manner as under the Company’s 2005 Executive Deferred Compensation Plan, as amended on the same date as the amendment to this Plan. 

Article IV 

Distributions 
 4.1. Ordinary Course Distributions. Except as otherwise expressly provided herein, all distributions of the Accounts shall be made in accordance with the Distribution Elections which relate to
deferrals made for each Plan Year. A Participant may make separate Deferral Elections for the sub-accounts of Accounts A, B and C. Distributions from the sub-accounts of Account A and C shall be in (a) the total number of shares of Fidelity
Stock deemed credited to the Participant’s Accounts A or C, to the extent the relevant sub-accounts of Accounts A or C are 

  
 8 

 
denominated in shares of Fidelity Stock and (b) on and after July 6, 2011, cash to the extent the amounts in the relevant sub-accounts of Account B are denominated in notional Common
Shares; provided, however, that the Participant may elect to have such cash distributed to a brokerage account in accordance with the terms and provisions of the election documentation provided to such Participant by the Company, which shall include
an agreement by the Company to cause any applicable fees and commissions to be waived to the extent such cash distribution is used to purchase Common Shares in accordance with the terms and provisions of such election documentation. Distributions
from the sub-accounts of Account B shall be in cash. Distribution Elections are irrevocable, and may not be modified, unless allowed under Section 409A of the Code, any guidance promulgated thereunder, or any successor thereto. If a
Participant does not timely file a Distribution Election in the year prior to the year to which the compensation relates, he will be deemed to have elected payment in five (5) annual installments. If a Participant files only one Distribution
Election for any Plan Year, it will be deemed to cover the deferrals into Accounts A, B and C for such Plan Year (and any earnings thereon), unless the Participant otherwise designates. Notwithstanding anything herein contained to the contrary,
(a) no distribution will be made to a Participant unless the Participant has a Separation from Service as regards the Company and (b) each Participant will have until December 31, 2007 to make a separate Distribution Election as
regards the Restricted Stock Units awarded to each Director as an incremental stock award in connection with the Separation Transaction (the “Separation Transaction RSUs”); provided, however, that if a Participant has not
made a Distribution Election prior to January 1, 2008, the Separation Transaction RSUs will be distributed in a lump sum within thirty days after such Participant’s Separation from Service. 

4.2. Distribution After Death of a Participant. If a Participant ceases to be a Director by reason of his death or if he dies
after he is no longer a Director, but prior to the distribution to him of all amounts payable to him under the Plan, the amounts that would otherwise be distributable to him, if living, shall be distributed to his designated beneficiary or
beneficiaries and any reference to a Participant in Paragraph 4.1, above, shall be deemed to include a reference to his designated beneficiary or beneficiaries unless the Participant otherwise elects on forms provided by the Committee. All
beneficiary designations shall be made in such form and manner as from time to time may be prescribed by the Committee. A Participant from time to time may revoke or change any beneficiary designation on file with the Committee. If there is no
effective beneficiary designation on file with the Committee at the time of the Participant’s death, distribution of amounts otherwise payable to the deceased Participant under this Plan shall be made to his estate or its successors or assigns.
If a beneficiary designated by a Participant to receive his benefit shall survive the Participant but die before receiving all distributions hereunder, the balance thereof shall be paid to such deceased beneficiaries’ estate or its successors
or assigns, unless the deceased Participant’s beneficiary designation provides otherwise. 
 4.3. Accounts Less than USD
$25,000. Notwithstanding anything herein contained to the contrary, if the sum of the Fair Market Value of the notional Common Shares and notional Fidelity Stock, if any, deemed to be held in a Participant’s Accounts A and C and the dollar
amount in a Participant’s Account B is less than USD $25,000 in total at the end of the Plan Year after the Participant has a Separation of Service from the Company, the Accounts shall be distributed

  
 9 

 
in a lump sum no later than the February 15 immediately following the year end in which this occurs. The notional Common Shares deemed invested in Accounts A and C shall be distributed in
cash, whether distributed in the form of cash or distributed to a brokerage account pursuant to Section 4.1 hereof. 
 4.4.
Change in Control. Notwithstanding anything contained herein or in the Distribution Elections, a Participant’s Accounts shall be distributed in a lump sum if the Participant has a Separation of Service as regards the Company on the date
when, or within a year after, a Change in Control takes place. Such distributions shall be made no later than forty-five days after the Participant has a Separation of Service as regards the Company. 

Article V 

Rights, Privileges and Duties of Participants 
 5.1. Rights of Participant. No Participant or any other person shall have any interest in any fund or in any specific asset or assets of the Company by reason of any amounts credited to any Account
hereunder, nor any right to exercise any of the rights or privileges of a stockholder with respect to any notional securities deemed credited to a Participant’s Account A or Account C under the Plan, nor any right to receive any distributions
under the Plan except as and to the extent expressly provided in the Plan. 
 5.2. Copy of Plan. Each Participant shall
be entitled, upon his request to the Secretary of the Company, to receive the most current version of the Plan. 
 5.3. No
Alienation. To the extent permitted by law, the right of any Participant or any beneficiary to receive any payment hereunder shall not be subject to alienation, transfer, sale, assignment, pledge, attachment, garnishment or encumbrance of any
kind. Any attempt to alienate, sell, transfer, assign, pledge or otherwise encumber any such payments whether presently or thereafter payable shall be void. Any payment due hereunder shall not in any manner be subject to debts or liabilities of any
Participant or his beneficiary. 
 5.4. Mental Competence. Every person receiving or claiming payments or rights under
the Plan shall be conclusively presumed to be mentally competent until the date on which the Committee receives a written notice in a form and manner acceptable to the Committee that such person is incompetent and that a guardian, conservator or
other person legally vested with the interest of his estate has been appointed. In the event a guardian or conservator of the estate of any person receiving or claiming payments under the Plan shall be appointed by a court of competent jurisdiction,
payments under this Plan may be made to such guardian or conservator provided that proper proof of appointment and continuing qualification is furnished in a form and manner acceptable to the Committee. Any such payments so made shall be a complete
discharge of any liability therefor. 
 5.5. Provision of Information. Each person, whether a Participant, a duly
designated beneficiary of a Participant, a guardian or any other person entitled to receive a payment under 

  
 10 

 
this Plan shall provide the Committee with such information as it may from time to time deem necessary or in its best interests in administering the Plan. Any such person shall also furnish the
Committee with such documents, evidence, data or other information as the Committee may from time to time deem necessary or advisable 
 Article VI 
 Administration of the Plan 

6.1. Appointment of Separate Administrator. The Committee may, in its sole discretion, in writing, appoint a separate
Administrator. Any person including, but not limited to, an employee or executive of Bank of Montreal or the Company or any of their respective subsidiaries, or a committee comprised of directors, employees and/or executives of a direct or indirect
parent of the Company, shall be eligible to serve as Administrator. Two or more persons may form a committee to serve as Administrator. Persons serving as Administrator may resign by written notice to the Committee and the Committee may appoint or
remove such persons. An Administrator consisting of more than one person shall act by a majority of its members at the time in office. An Administrator consisting of more than one person may authorize any one or more of its members to execute any
document or documents on behalf of the Administrator, in which event the Administrator shall notify the Committee of the member or members so designated. The Committee shall accept and rely upon any document executed by such member or members as
written revocation of such designation. No person serving as Administrator shall vote or decide upon any matter relating solely to himself or solely to any of his rights or benefits pursuant to the Plan. 

6.2. Powers and Duties. The Administrator shall administer the Plan in accordance with its terms. The Administrator shall have
full and complete authority and control with respect to Plan operations and administration unless the Administrator allocates and delegates such authority or control pursuant to the procedures stated in subsection b. or c. below. Any decisions of
the Administrator or its delegate shall be final and binding upon all persons dealing with the Plan or claiming any benefit under the Plan. The Administrator shall have all powers which are necessary to manage and control Plan operations and
administration including, but not limited to, the following: 
  

	 	a.	To employ such accountants, counsel or other persons as it deems necessary or desirable in connection with Plan administration. The Company shall bear the costs of such
services and other administrative expenses. 

  

	 	b.	To designate in writing persons other than the Administrator to perform any of its powers and duties hereunder. 

 

	 	c.	The discretionary authority to construe and interpret the Plan, including the power to construe disputed provisions. 

 

	 	d.	To resolve all questions arising in the administration, interpretation and application of the Plan including, but not limited to, questions as to the eligibility or the
right of any person to a benefit. 

  
 11 

	 	e.	To adopt such rules, regulations, forms and procedures from time to time as it deems advisable and appropriate in the proper administration of the Plan.

  

	 	f.	To prescribe procedures to be followed by any person in applying for distributions pursuant to the Plan and to designate the forms or documents, evidence and such other
information as the Administrator may reasonably deem necessary, desirable or convenient to support an application for such distribution. 

 6.3. Records and Notices. The Administrator shall maintain all books of accounts, records and other data as may be necessary for proper plan administration. 

6.4. Compensation and Expenses. The expenses incurred by the Administrator in the proper administration of the Plan shall be paid
by the Company. An Administrator who is an employee shall not receive any additional fee or compensation for services rendered as an Administrator. 
 6.5. Limitation of Authority. The Administrator shall not add to, subtract from or modify any of the terms of the Plan, change or add to any benefits prescribed by the Plan, or waive or fail to
apply any Plan requirement for benefit eligibility. 
 6.6 Claims Procedures. A Participant or a Participant’s
beneficiary shall be entitled to make a request for any benefits to which he or she believes are entitled under the Plan. Any such request must be made in writing, and it should be made to the Company. A request for benefits will be considered a
claim, and it will be subject to a full and fair review. If a Participant’s claim is wholly or partially denied, the Company shall furnish the Participant or the Participant’s beneficiary (the “Claimant”) or the Claimant’s
authorized representative with a written or electronic notice of the denial within a reasonable period of time, which sets forth, in an understandable manner the reasons for denial. 

6.7 Communication with the Trust. Notwithstanding anything to the contrary herein, neither the Committee nor the Administrator may
communicate under any circumstances, either orally or in writing, with the trustee of the Trust, or an agent thereof. Only the Company, or an agent thereof, may communicate, orally or in writing, with the trustee of the Trust in accordance with the
terms herein and the terms of the Trust, as either may be amended from time to time. 
 Article VII 

Amendment or Termination 
 The Board of Directors of the Company prior to the Merger, and the Board of Directors of Bank of Montreal following the Merger, may at any time terminate, suspend, alter or amend this Plan so long as such
actions do not contravene the requirements of Section 409A of the Code. No Participant or any other person shall have any right, title, interest or claim against the Company, its directors, officers or employees for any amounts, except that
(i) the Participant 

  
 12 

 
shall be fully vested in his or her Accounts hereunder as of the date on which the Plan is terminated or suspended, (ii) no amendment shall eliminate the crediting of an investment return on
the sub-accounts of Account B prior to the complete distribution thereof or provide for a distribution method which accelerates the timing of distributions hereunder without the consent of a Participant and (iii) subsequent to a Change in
Control, unless a majority of the holders of Account balances agree to the contrary, the Company or the Administrator may not alter (a) the choice of investments as in effect immediately before the Change in Control and (b) the payment
options contained in the Distribution Elections as in effect immediately before the Change in Control. Notwithstanding the foregoing, the Board of Directors of the Company prior to the Merger, and the Board of Directors of Bank of Montreal following
the Merger, may make any amendment necessary in order to avoid penalties under Section 409A of the Code, even if such amendments are detrimental to Participants. 
 Article VIII 
 Miscellaneous 

8.1. Construction. Wherever the context so requires, words in the masculine include the feminine and words in the feminine include
the masculine and the definition of any term in the singular may include the plural. 
 8.2. Expenses. All expenses of
administering the Plan shall be paid by the Company except as expressly provided herein to the contrary. 
 8.3. Governing
Law. The Plan shall be construed, administered and governed in all respects under and by the laws of the State of Wisconsin, without giving effect to its conflicts of law provisions. 

8.4. Tenure Not Guaranteed by Plan. The establishment of this Plan and the designation of a Director as a Participant, shall not
give any Participant the right to continued as a Director or limit the right of any of the Companies to dismiss the Director or fail to nominate the Director for reelection. 
 8.5. Notice. Any and all notices, designations or reports provided for herein shall be in writing and delivered personally, by certified mail, return receipt requested, or by electronic means.
Physical deliveries shall be addressed, in the case of the Company, to the Plan Administrator at 770 North Water Street, Milwaukee, Wisconsin 53202 and, in the case of a Participant or Beneficiary, to his home address as shown on the records of the
Company. The addresses referenced herein may be changed by a notice delivered in accordance with the requirement of this Paragraph 8.5. 
 8.6. Indemnification. The Company shall indemnify the Administrator and any employee, officer or director of the Company against all liabilities arising by reason of any act or failure to act
unless such act or failure to act is due to such person’s own gross negligence or willful misconduct or lack of good faith in the performance of his duties to the Plan or the Trust. Such indemnification shall include, but not be limited to,
expenses reasonably incurred in the 

  
 13 

 
defense of any claim, including reasonable attorney and legal fees, and amounts paid in any settlement or compromise; provided, however, that indemnification shall not occur to the extent that it
is not permitted by applicable law. Indemnification shall not be deemed the exclusive remedy of any person entitled to indemnification pursuant to this section. The indemnification provided hereunder shall continue as to a person who has ceased
acting as a director, officer, member, agent or employee of the Administrator or as an officer, director or employee of the Company and such person’s rights shall inure to the benefit of his heirs and representatives. 

8.7. Effective Date. This Plan was initially effective as of December 16, 2004. 

8.8. Compliance with Section 409A of the Code. This Plan shall be interpreted and administered in compliance with the
requirements of Section 409A of the Code and any guidance promulgated thereunder, including the final regulations. Any ambiguous language shall be interpreted in a manner which makes it compliant with Section 409A of the Code and the
applicable guidance. 
 8.9. December 2010 Amendments to Comply with Section 409A of the Code. The following
amendments were made to all plans, agreements and arrangements of the Company and its subsidiaries which provide for compensation and/or benefits which are nonqualified deferred compensation for purposes of Section 409A of the Code
(collectively referred to hereinafter as “Compensation Arrangements”), which include the Plan, on December 16, 2010 by the Board of Directors of the Company. 

 

	 	1.	Where any payment under a Compensation Arrangement is to be made at the time of a “change of control” or “triggering event,” (or a similar term) of
the Company or one of its subsidiaries, such payment shall only be made if the “change of control” or “triggering event” is also a “change of control” for purposes of Code Section 409A. 

 

	 	2.	Where any payment or benefit under a Compensation Arrangement is “nonqualified deferred compensation” for purposes of Code Section 409A, if the payment
or benefit is to be made or provided upon a termination of employment or service of the employee or director or upon a specified period of time thereafter, such payment or benefit shall only be made or provided at the time of the employee or
director’s “separation from service” (as defined under Code Section 409A) or the same specified period of time thereafter. 

  

	 	3.	Where any payment or benefit under a Compensation Arrangement is “nonqualified deferred compensation” for purposes of Code Section 409A, if the payment
is to be made or provided upon a termination of employment or service of the employee or upon a specified period of time thereafter, if the employee is a “specified employee” for purposes of Code Section 409A, any payments or benefits
that would otherwise be made or provided during the six- month period following the date of the employee’s separation from service shall be accrued and shall not be paid or provided until the first business day of the Company following the six
month anniversary of the employee’s separation from service. 

  
 14 

	 	4.	Any tax gross up payments provided for in a Compensation Arrangement (including, but not limited to, the Change of Control Agreements the Company has entered into with
certain executives) shall be required to be paid to the executive no later than the end of the employee’s tax year following the year in which the employee remits the taxes. 

 

	 	5.	Any payments under a Compensation Arrangement which are payable upon an employee’s termination of employment and which are conditioned on the employee signing a
release in favor of the Company shall be revised to commence (a) within the 60-day period following the date of the employee’s separation from service, and where the 60-day period following such separation spans two different calendar
years, such payment(s) will not commence until the later calendar year during such 60-day period, or, if later, (b) upon the commencement date of such payments currently specified in such Compensation Agreement; provided, however, that
if a payment is required to be delayed for six months because the employee is a “specified employee” for purposes of Section 409A, the delayed payment shall be made in a lump sum on the first business day of the Company following the
six-month anniversary of the employee’s “separation from service” or, if later, upon the commencement date of such payment(s) currently specified in such Compensation Agreement. Any such Compensation Agreement shall be revised to
require the employee to sign release, and for the rescission period to expire without revocation of the release within 60 days following the date of the employee’s “separation from service” or otherwise forfeit the compensation and
benefits provided thereunder. 

  

	 	6.	Any other changes required to make the Compensation Arrangements compliant with the requirement of Section 409A of the Code or the regulations promulgated
thereunder shall be made. 

  
 15Fourth Amended and Restated Employment Agreement

 Exhibit 10.1 
 FOURTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS FOURTH AMENDED AND
RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into this 1st day of July, 2011 (the “Effective Date”) by and between Immunomedics, Inc., a Delaware corporation having its principal offices in Morris Plains, New
Jersey (the “Company”), and Cynthia L. Sullivan (the “Executive”). 
 WHEREAS, the Executive is presently
employed by the Company in the capacity of President and Chief Executive Officer, pursuant to that certain Third Amended and Restated Employment Agreement between the Company and Executive (the “Prior Employment Agreement”), dated
June 15, 2010; 
 WHEREAS, the Company desires to continue to employ the Executive as its President and Chief Executive
Officer, and the Executive desires to continue to serve in such capacity on behalf of the Company, upon the terms and conditions hereinafter set forth; 
 WHEREAS, the Company and the Executive desire to amend and restate the terms and conditions of the Prior Employment Agreement in order to reflect certain desired changes and clarifications in the terms
and continue Executive’s employment with the Company upon the amended and restated terms and conditions of this Agreement; 

WHEREAS, the Executive acknowledges that she has had an opportunity to consider this Agreement and consult with an independent advisor(s)
of her choosing with regard to the terms of this Agreement, and enters into this Agreement voluntarily and with a full understanding of its terms; and 
 WHEREAS, the Company and the Executive have agreed that this Agreement will supersede and replace the Prior Employment Agreement as of the Effective Date. 

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows: 

1.1 Term. This Agreement and the Term shall terminate on July 1, 2014 (the “Term”), unless sooner terminated by
either party as hereinafter provided. The expiration of this Agreement in the absence of a successor employment agreement shall be deemed a termination of the Executive’s employment for purposes of this Agreement, including a termination
without Cause for purposes of Section 2; provided, however, that if the Company presents to the Executive, on or before March 1, 2014, a written offer to extend the Term on substantially the same terms and conditions as set forth in this
Agreement or on terms and conditions that, in the aggregate, are more economically favorable to the Executive than as set forth in this Agreement, as determined in the good faith discretion of the Compensation Committee of the Board of Directors of
the Company, and the Executive does not accept such offer, then the expiration of this Agreement in the absence of a successor employment agreement shall be deemed a termination of the Executive’s employment for purposes of this Agreement,
including a voluntary termination for purposes of Section 2.4. 
 1.2 Duties and Responsibilities. Commencing on the
Effective Date, Executive shall continue to serve as the President and Chief Executive Officer of the Company and shall perform all duties and accept all responsibilities incident to such position as may be reasonably assigned to Executive by the
Company’s Board of Directors (the “Board”). 
 1.3 Extent of Service. Executive agrees to use
Executive’s best efforts to carry out Executive’s duties and responsibilities under Section 1.2 hereof and, consistent with the other provisions of this Agreement, to devote substantially all of Executive’s business time,
attention and energy thereto. The foregoing shall not be construed as preventing Executive from making investments in other businesses or enterprises, provided that Executive agrees not to become engaged in any other business activity which, in the
reasonable judgment of the Board, is likely to interfere with Executive’s ability to discharge Executive’s duties and responsibilities to the Company. 
 1.4 Base Salary. For all the services rendered by Executive hereunder, the Company shall pay Executive a base salary (“Base Salary”) at the annual rate of $558,600, payable bi-weekly in
installments at such times as the Company customarily pays its other senior level executives. Executive’s Base Salary shall be reviewed annually for appropriate increases by the Board or Compensation Committee of the Board (the
“Compensation Committee”) pursuant to the normal performance review policies for senior level executives. 
 1.5
Annual Bonus. During the Term, the Executive shall be eligible to participate in the Company’s incentive compensation plan in place from time to time for its senior level executives generally, at levels determined by the Compensation
Committee. The Company reserves the right to amend or rescind the incentive compensation plan at 

 
any time in its discretion. In connection with Executive’s participation in the incentive compensation plan, the Executive shall be eligible to receive an annual discretionary bonus. The
amount of the annual discretionary bonus, if any, will be determined by the Compensation Committee in its discretion, based on the Executive’s individual performance and Company performance as determined by the Compensation Committee. The
Executive’s annual bonus target is 50% of Base Salary, subject to achievement of performance goals to be established by the Compensation Committee, with a potential payout from 0 to 150% of the target amount depending upon achievement of the
performance goals. The discretionary annual bonus, if any, will be determined as of the end of each fiscal year during the Term and shall be paid as soon as practicable after the end of each fiscal year to which the bonus relates, but in no event,
later than 2-  1/2 months after the end of such
fiscal year, except as provided in Section 2. Except as otherwise specifically provided in Section 2, to be eligible to receive an annual bonus, or any portion thereof, the Executive must be employed by the Company both at the time the
amount of the annual bonus, if any, is determined, and at the time the annual bonus, if any, is paid. 
 1.6 Equity
Compensation. During the Term, pursuant to the terms and conditions of the Company’s 2006 Stock Incentive Plan or any successor equity compensation plan as may be in place from time to time, the Executive shall be eligible to receive, from
time to time, awards in amounts, and subject to such terms, conditions and restrictions, as determined by the Compensation Committee in its sole discretion. Awards granted to the Executive, if any, shall be subject to the terms and conditions
established within the Company’s 2006 Stock Incentive Plan (as amended from time to time) or any successor equity compensation plan as may be in place from time to time, as applicable, and the separate option agreement, restricted stock
purchase agreement or stock award agreement between the Company and the Executive that sets forth the terms and conditions of the award (e.g., exercise price, expiration date and vesting schedule of stock options; and the restricted period
and/or other restrictions such as performance objectives relating to stock awards). 
 1.7 Retirement and Welfare Plans.
During the Term, Executive shall participate in employee retirement and welfare benefit plans made available to the Company’s senior level executives as a group or to its employees generally, as such retirement and welfare plans may be in
effect from time to time and subject to the eligibility requirements of the plans. Nothing in this Agreement shall prevent the Company from amending or terminating any retirement, welfare or other employee benefit plans or programs from time to time
as the Company deems appropriate. 
 1.8 Reimbursement of Expenses; Vacation. During the Term, Executive shall be
provided with reimbursement of reasonable expenses related to Executive’s employment by the Company on a basis no less favorable than that which may be authorized from time to time for senior level executives as a group, and shall be entitled
to six (6) weeks of vacation in accordance with the Company’s pay for time not worked policies. 
 2.
Termination. Executive’s employment shall terminate upon the occurrence of any of the following events: 
 2.1
Termination Without Cause or Resignation for Good Reason Before A Change of Control. 
 (a) The Company may remove
Executive at any time without Cause (as defined in Section 2.9) from the position in which Executive is employed hereunder upon not less than 30 days’ prior written notice to Executive. The Company shall have discretion to terminate
Executive’s employment during the notice period and pay continued Base Salary in lieu of notice. In addition, Executive may initiate a termination of employment by resigning under this Section 2.1 for Good Reason (as defined in, and in
accordance with the notice provisions set forth in Section 2.9). 
 (b) If Executive’s employment terminates as
described in subsection (a) above and Executive executes and does not revoke a written release upon such removal, in a form provided by the Company, of any and all claims against the Company and all related parties with respect to all matters
arising out of Executive’s employment by the Company, or the termination thereof (the “Release”), Executive shall be entitled to receive the following severance compensation, as long as Executive complies with the terms of Sections 4,
5, 6 and 7 below: 
 (i) Executive shall receive severance payments in an amount equal to the sum of: (x) being 2.00 times
Executive’s annual Base Salary at the rate in effect at the time of Executive’s termination, and (y) being 2.00 times Executive’s target bonus established for the fiscal year in which the date of termination occurs. The severance
amount shall be paid in separate equal monthly payments over the 24-month period following Executive’s termination of employment. 

  
 2 

 (ii) The Company shall, for a period of 18 months following the date of Executive’s
termination of employment, pay Executive each month an amount equal to the monthly COBRA medical insurance cost under the Company’s medical plan for Executive, and, where applicable, her spouse and eligible dependents, less an amount equal to
the required monthly employee payment for such coverage calculated as if Executive had continued to be an employee of the Company throughout such period; provided that Executive, and, where applicable, her spouse and eligible dependents, are
eligible for and timely elect to receive COBRA healthcare continuation coverage and provided further that the payments specified under this Section 2.1(b)(ii) shall cease if the Company’s statutory obligation to provide such COBRA
healthcare continuation coverage terminates for any reason before the expiration of the 18-month period. 
 (iii) Executive
shall receive any benefits earned, accrued and due in accordance with the terms of any applicable benefit plans and programs of the Company. In addition, Executive shall be entitled to the annual bonus earned based on actual performance, if any,
payable for the fiscal year in which the termination occurs (prorated to reflect Executive’s actual period of service during such fiscal year) paid in accordance with Section 1.5 without regard to the last sentence of Section 1.5.

 (iv) Except as otherwise required by Section 2.10, the benefits described in subsections (i) and (ii) above
shall begin within 60 days after Executive’s termination date, subject to Executive’s execution and non-revocation of the Release; provided that notwithstanding any provision of this Agreement to the contrary, in no event shall the timing
of Executive’s execution of the Release, directly or indirectly, result in Executive designating the calendar year of payment, and if a payment that is subject to execution of the Release could be made in more than one taxable year, payment
shall be made in the later taxable year. The Company shall provide the Release to Executive on or before the termination date, and Executive shall execute the Release during the time period permitted by applicable law. 

(v) Executive agrees that if Executive fails to comply with Section 4, 5, 6 or 7 below, all payments under this Section 2.1
shall immediately cease. 
 2.2 Termination Without Cause or Resignation for Good Reason After A Change of Control.

 (a) If a Change of Control occurs and, during the one-year period commencing on the date of the Change of Control, the
Company terminates Executive’s employment without Cause (upon not less than 30 days’ prior written notice to Executive) or Executive resigns for Good Reason (as defined in, and in accordance with the notice provisions set forth in
Section 2.9), this Section 2.2 shall apply in lieu of Section 2.1. The Company shall have discretion to terminate Executive’s employment during the notice period and pay continued Base Salary in lieu of notice. 

(b) If Executive’s employment terminates as described in subsection (a) above and Executive executes and does not revoke a
Release, Executive shall be entitled to receive the following severance compensation, as long as Executive complies with the terms of Sections 4, 5, 6 and 7 below: 
 (i) Executive shall receive a lump sum severance payment in an amount equal to 3.00 times the sum of Executive’s annual Base Salary at the rate in effect at the time of Executive’s termination
and Executive’s target bonus for the calendar year in which the date of termination occurs. 
 (ii) The Company shall, for
a period of 18 months following the date of Executive’s termination of employment, pay Executive each month an amount equal to the monthly COBRA medical insurance cost under the Company’s medical plan for Executive, and, where applicable,
her spouse and eligible dependents, less an amount equal to the required monthly employee payment for such coverage calculated as if Executive had continued to be an employee of the Company throughout such period; provided that Executive, and, where
applicable, her spouse and eligible dependents, are eligible for and timely elect to receive COBRA healthcare continuation coverage and provided further that the payments specified under this Section 2.2(b)(ii) shall cease if the Company’s
statutory obligation to provide such COBRA healthcare continuation coverage terminates for any reason before the expiration of the 18-month period. 
 (iii) Executive shall receive any benefits earned, accrued and due in accordance with the terms of any applicable benefit plans and programs of the Company. In addition, Executive shall be entitled to the
annual bonus earned based on actual performance, if any, payable for the fiscal year in which the termination occurs (prorated to reflect Executive’s actual period of service during such fiscal year) paid in accordance with Section 1.5
without regard to the last sentence of Section 1.5. 

  
 3 

 (iv) Except as otherwise required by Section 2.10, the lump sum payment described in
subsection (i) shall be made, and the monthly payments described in subsection (ii) above shall begin, within 60 days after Executive’s termination date, subject to Executive’s execution and non-revocation of the Release;
provided that notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of Executive’s execution of the Release, directly or indirectly, result in Executive designating the calendar year of payment, and if a
payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year. The Company shall provide the Release to Executive on or before the termination date, and Executive
shall execute the Release during the time period permitted by applicable law. 
 (v) Notwithstanding any provision to the
contrary in the Company’s 2006 Stock Incentive Plan or any applicable plan, program or agreement, all stock options, restricted stock and other equity rights held by the Executive will become fully vested and/or exercisable, as the case may be,
on the Executive’s termination date, and all stock options held by the Executive shall remain exercisable, notwithstanding anything in any other agreement governing such options, for a period of 24 months following the end of the remaining
balance of the Term of the Agreement; provided, however, that in no event will the option be exercisable (i) beyond its original term; or (ii) beyond the extension period permitted under section 409A of the Code. 

(c) Notwithstanding any vesting provision to the contrary in any applicable plan, program or agreement providing for supplemental
retirement benefits or deferred compensation, upon the occurrence of a Change of Control, Executive’s accrued benefit under such plans, programs or agreements shall become fully vested on the date on which the Change in Control occurs, and
Executive’s accrued benefit shall be immediately payable on the Executive’s date of termination, unless the Executive has made a valid election under such plan, program or agreement to defer payment of such accrued benefits or the
Executive’s accrued benefit constitutes “deferred compensation” within the meaning of section 409A of the Code and the terms of the applicable plan, program or agreement provide otherwise with respect to the timing of payment of the
accrued benefit. 
 (d) Executive agrees that if Executive materially breaches Section 4, 5, 6 or 7 below, all payments and
benefits under this Section 2.2 shall immediately cease. 
 2.3 [INTENTIONALLY OMITTED] 

2.4 Voluntary Termination. Executive may voluntarily terminate Executive’s employment for any reason upon 30 days’ prior
written notice. In such event, after the effective date of such termination, except as provided in Section 2.2 with respect to a resignation for Good Reason, no further payments shall be due under this Agreement, except that Executive shall be
entitled to any benefits earned, accrued and due in accordance with the terms of any applicable benefit plans and programs of the Company. 
 2.5 Disability. The Company may terminate Executive’s employment if Executive has been unable to perform the material duties of Executive’s employment for a period of 90 days in any
12-month period because of physical or mental injury or illness (“Disability”); provided, however, that the Company shall continue to pay Executive’s Base Salary until the Company acts to terminate Executive’s employment.
Notwithstanding the foregoing, the Executive shall be deemed terminated for Disability if the Executive is disabled for a period of 12 months. Executive agrees, in the event of a dispute under this Section 2.5 relating to Executive’s
Disability, to submit to a physical examination by a licensed physician jointly selected by the Board and Executive. If the Company terminates Executive’s employment for Disability, no further payments shall be due under this Agreement, except
that Executive shall be entitled to any benefits earned, accrued and due in accordance with the terms of any applicable benefit plans and programs of the Company. In addition, Executive shall be entitled to the annual bonus earned based on actual
performance, if any, payable for the fiscal year in which the termination occurs (prorated to the date Executive is determined to have a Disability) paid in accordance with Section 1.5 without regard to the last sentence of Section 1.5.

 2.6 Death. If Executive dies while employed by the Company, the Company shall pay to Executive’s executor, legal
representative, administrator or designated beneficiary, as applicable, any benefits earned, accrued and due under the Company’s benefit plans and programs in accordance with the terms and conditions contained therein. Otherwise, the Company
shall have no further liability or obligation under this Agreement to Executive’s executors, legal representatives, administrators, heirs or assigns or any other person claiming under or through Executive. In addition, Executive shall be
entitled to the annual bonus earned based on actual performance, if any, payable for the fiscal year in which the termination occurs (prorated to reflect Executive’s actual period of service during such fiscal year) paid in accordance with
Section 1.5 without regard to the last sentence of Section 1.5. 

  
 4 

 2.7 Cause. The Company may terminate Executive’s employment at any time for
Cause (as defined in Section 2.9) upon written notice to Executive, in which event all payments under this Agreement shall cease. Executive shall be entitled to any benefits earned, accrued and due before Executive’s termination in
accordance with the terms of any applicable benefit plans and programs of the Company. 
 2.8 Notice of Termination. Any
termination of Executive’s employment shall be communicated by a written notice of termination to the other party hereto given in accordance with Section 11. The notice of termination shall (a) indicate the specific termination
provision in this Agreement relied upon, (b) briefly summarize the facts and circumstances deemed to provide a basis for a termination of employment and the applicable provision hereof, and (c) specify the termination date in accordance
with the requirements of this Agreement. 
 2.9 Definitions. 

(a) “Cause” shall mean any of the following grounds for termination of Executive’s employment: 

(i) Executive shall have been convicted of a felony, or enters in a plea of guilty or nolo contendere with respect thereto;

 (ii) Executive intentionally and continually fails to perform Executive’s reasonably assigned material duties to the
Company (other than a failure resulting from Executive’s incapacity due to physical or mental illness), which failure has continued for a period of at least 30 days after a written notice of demand for substantial performance, signed by a duly
authorized officer of the Company, has been delivered to Executive specifying the manner in which Executive has failed substantially to perform; 
 (iii) Executive causes material, intentional, wrongful damage to the property of the Company; 
 (iv) Executive engages in public conduct that is harmful to the reputation of the Company; 
 (v) Executive engages in willful misconduct in the performance of Executive’s duties; or 
 (vi) Executive materially breaches Sections 4, 5, 6 or 7 below. 
 (b)
“Change of Control” shall mean: 
 (i) A merger, consolidation or reorganization approved by the
Company’s stockholders, unless securities representing more than 50% of the total and combined voting power of the outstanding voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly,
by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; or 
 (ii) The sale, transfer or other disposition of all or substantially all of the Company’s assets as an entirety or substantially as an entirety, occurring within a 12-month period, and representing,
at a minimum, not less than 40% of the total gross fair market value of all assets of the Company, to any person, entity, or group of persons acting in consort, other than a sale, transfer or disposition to: (A) a stockholder of the Company in
exchange for or with respect to its stock; (B) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company; (C) a person, or more than one person acting as a group, that owns,
directly or indirectly, 50% or more of the total value or voting power of the outstanding stock of the Company; or (D) an entity, at least 50% of the total value or voting power of which is owned by a person described in (C); or 

(iii) Any transaction or series of related transactions pursuant to which any person or any group of persons comprising a
“group” within the meaning of Rule 13d-5(b)(l) under the Securities Exchange Act of 1934, as amended (other than the Company or a person that, prior to such transaction or series of related transactions, directly or indirectly controls, is
controlled by or is under common control with, the Company) becomes directly or indirectly the beneficial owner (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of securities possessing (or convertible into or
exercisable for securities possessing) more than 50% of the total combined voting power of the Company’s securities outstanding immediately after the consummation of such transaction or series of related transactions, whether such transaction
involves a direct issuance from the Company or the acquisition of outstanding securities held by one or more of the Company’s stockholders; or 
 (iv) A change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases by reason of one or more contested elections for Board
membership to be comprised of individuals whose election is endorsed by a majority of the members of the Board immediately before the date of election. 

  
 5 

 A transaction shall not constitute a Change of Control if its sole purpose is to change the state of the
Company’s incorporation or to create a holding company that will be owned in the same proportions by the persons who held the Company’s securities immediately before such transaction. 

(c) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(d) “Good Reason” shall mean the occurrence of any of the following events or conditions, unless Executive has expressly
consented in writing thereto, or except as a result of Executive’s physical or mental incapacity or as described in the last sentence of this subsection (d): 
 (i) A material reduction in Executive’s Base Salary; 
 (ii) The material
diminution of the Executive’s duties, responsibilities, powers or authorities, including the assignment of any duties and responsibilities inconsistent with her position as President and Chief Executive Officer; 

(iii) The Company requires that Executive’s principal office location be moved to a location more than 50 miles form
Executive’s principal office location immediately before the change; 
 (iv) The failure of the Company to obtain the
assumption of the obligations contained herein by any successor; or 
 (v) On or after a Change of Control, the removal of
Executive from her office as President and Chief Executive Officer or a material reduction of Executive’s primary functional authorities, duties, or responsibilities as President and Chief Executive Officer of the Company from those in effect
immediately prior to the Change of Control or the assignment of duties to Executive inconsistent with those of President and Chief Executive Officer of the Company, other than an insubstantial and inadvertent reduction or assignment that is remedied
by the Company promptly after receipt of notice thereof given by Executive in accordance with the notice provisions below. 
 Notwithstanding
the foregoing, Executive shall not have Good Reason for termination unless Executive gives written notice of termination for Good Reason within 15 days after the event or condition giving rise to Good Reason occurs and the Company does not correct
the action or failure to act that constitutes the grounds for Good Reason, as set forth in Executive’s notice of termination, within 30 days after the date on which Executive gives written notice of termination and the Executive actually
resigns from employment upon the expiration of the foregoing cure period. In the event of a cure of such event or condition constituting Good Reason by the Company, such event or condition shall no longer constitute Good Reason. 

2.10 Required Postponement for Specified Executives. 
 (a) If Executive is considered a Specified Executive (as defined below) and payment of any amounts under this Agreement is required to be delayed for a period of six months after separation from service
pursuant to section 409A of the Code, payment of such amounts shall be delayed as required by section 409A of the Code, and the accumulated postponed amounts, with accrued interest as described below, shall be paid in a lump sum payment within five
days after the end of the six month period. If Executive dies during the postponement period prior to the payment of benefits, the amounts postponed on account of section 409A of the Code, with accrued interest as described in subsection
(b) below, shall be paid to the personal representative of Executive’s estate within 60 days after the date of Executive’s death. 
 (b) If payment of any amounts under this Agreement is required to be delayed pursuant to Section 2.10(a), the Company shall pay interest on the postponed payments from the date on which the amounts
otherwise would have been paid to the date on which such amounts are paid at an annual rate equal to the rate published in the Wall Street Journal as the “prime rate” as of Executive’s date of termination. 

(c) The term “Specified Executive” means an employee who, at any time during the 12-month period ending on the identification
date (defined below), is (i) an officer of the Company or a member of its controlled group (as determined for purposes of section 416(i) of the Code) who has annual compensation greater than $160,000 (or such other amount as may be in effect
under section 416(i)(l) of the Code), (ii) a 5% owner of the Company or (iii) a 1% owner of the Company who has annual compensation greater than $150,000. The 

  
 6 

 
identification date shall be each December 31, and the determination of Specified Executives as of such identification date shall apply for the 12-month period following April 1 after
the identification date. The determination of Specified Executives, including the number and identity of persons considered officers, shall be made by the Company in accordance with the provisions of sections 416(i) and 409A of the Code and the
regulations issued thereunder. 
 3. Non-Exclusivity of Rights. Nothing in this Agreement shall prevent or limit Executive’s
continuing or future participation in or rights under any benefit, bonus, incentive or other plan or program provided by the Company and for which Executive may qualify; provided, however, that if Executive becomes entitled to and receives the
payments provided for in Section 2 of this Agreement, Executive hereby waives Executive’s right to receive payments under any severance plan or similar program applicable to all employees of the Company. 

4. Confidentiality. Executive agrees that Executive’s services to the Company and its subsidiaries and any successors or assigns
(collectively, the “Employer”) were and are of a special, unique and extraordinary character, and that Executive’s position places Executive in a position of confidence and trust with the Employer’s customers and employees.
Executive also recognizes that Executive’s position with the Employer will give Executive substantial access to Confidential Information (as defined below), the disclosure of which to competitors of the Employer would cause the Employer to
suffer substantial and irreparable damage. Executive recognizes, therefore, that it is in the Employer’s legitimate business interest to restrict Executive’s use of Confidential Information for any purposes other than the discharge of
Executive’s employment duties at the Employer, and to limit any potential appropriation of Confidential Information by Executive for the benefit of the Employer’s competitors and to the detriment of the Employer. Accordingly, Executive
agrees as follows: 
 (a) Executive will not at any time, whether during or after the termination of Executive’s
employment, reveal to any person or entity any of the trade secrets or confidential information of the Employer or of any third party which the Employer is under an obligation to keep confidential (including but not limited to trade secrets or
confidential information respecting inventions, products, designs, methods, know-how, techniques, systems, processes, software programs, works of authorship, customer lists, projects, plans and proposals) (“Confidential Information”),
except as may be required in the ordinary course of performing Executive’s duties as an employee of the Employer, and Executive shall keep secret all matters entrusted to Executive and shall not use or attempt to use any such information in any
manner which may injure or cause loss or may be calculated to injure or cause loss whether directly or indirectly to the Employer. 
 (b) The above restrictions shall not apply to: (i) information that at the time of disclosure is in the public domain through no fault of Executive; (ii) information received from a third party
outside of the Employer that was disclosed without a breach of any confidentiality obligation; (iii) information approved for release by written authorization of the Employer; or (iv) information that may be required by law or an order of
any court, agency or proceeding to be disclosed; provided Executive shall provide the Employer notice of any such required disclosure once Executive has knowledge of it and will help the Employer to the extent reasonable to obtain an appropriate
protective order. 
 (c) Further, Executive agrees that during Executive’s employment Executive shall not take, use or
permit to be used any notes, memoranda, reports, lists, records, drawings, sketches, specifications, software programs, data, documentation or other materials of any nature relating to any matter within the scope of the business of the Employer or
concerning any of its dealings or affairs otherwise than for the benefit of the Employer. Executive further agrees that Executive shall not, after the termination of Executive’s employment, use or permit to be used any such notes, memoranda,
reports, lists, records, drawings, sketches, specifications, software programs, data, documentation or other materials, it being agreed that all of the foregoing shall be and remain the sole and exclusive property of the Employer and that,
immediately upon the termination of Executive’s employment, Executive shall deliver all of the foregoing, and all copies thereof, to the Employer, at its main office. 
 (d) Executive agrees that upon the termination of Executive’s employment with the Employer, Executive will not take or retain without written authorization any documents, files or other property of
the Employer, and Executive will return promptly to the Employer any such documents, files or property in Executive’s possession or custody, including any copies thereof maintained in any medium or format. Executive recognizes that all
documents, files and property which Executive has received and will receive from the Employer, including but not limited to scientific research, customer lists, handbooks, memoranda, product specifications, and other materials (with the exception of
documents relating to benefits to which Executive might be entitled following the termination 

  
 7 

 
of Executive’s employment with the Employer), are for the exclusive use of the Employer and employees who are discharging their responsibilities on behalf of the Employer, and that Executive
has no claim or right to the continued use, possession or custody of such documents, files or property following the termination of Executive’s employment with the Employer. 
 5. Intellectual Property. 
 (a) If at any time or times during
Executive’s employment Executive shall (either alone or with others) make, conceive, discover or reduce to practice any invention, modification, discovery, design, development, improvement, process, software program, work of authorship,
documentation, formula, data, technique, know-how, secret or intellectual property right whatsoever or any interest therein (whether or not patentable or registrable under copyright or similar statutes or subject to analogous protection) (herein
called “Developments”) that (i) relates to the business of the Employer or any customer of or supplier to the Employer or any of the products or services being developed, manufactured or sold by the Employer or which may be used in
relation therewith, (ii) results from tasks assigned to Executive by the Employer or (iii) results from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Employer, such
Developments and the benefits thereof shall immediately become the sole and absolute property of the Employer and its assigns, and Executive shall promptly disclose to the Employer (or any persons designated by it) each such Development, and
Executive hereby assigns any rights Executive may have or acquire in the Developments and benefits and/or rights resulting therefrom to the Employer and its assigns without further compensation and shall communicate, without cost or delay, and
without publishing the same, all available information relating thereto (with all necessary plans and models) to the Employer. 

(b) Upon disclosure of each Development to the Employer, Executive will, during Executive’s employment and at any time thereafter,
at the request and cost of the Employer, sign, execute, make and do all such deeds, documents, acts and things as the Employer and its duly authorized agents may reasonably require: 

(i) to apply for, obtain and vest in the name of the Employer alone (unless the Employer otherwise directs) letters patent, copyrights
or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same; and 
 (ii) to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such letters patent, copyright or other analogous
protection. 
 (c) In the event the Employer is unable, after reasonable effort, to secure Executive’s signature on any
letters patent, copyright or other analogous protection relating to a Development, whether because of Executive’s physical or mental incapacity or for any other reason whatsoever, Executive hereby irrevocably designates and appoints the
Employer and its duly authorized officers and agents as Executive’s agent and attorney-in-fact, to act for and on Executive’s behalf and stead to execute and file any such application or applications and to do all other lawfully permitted
acts to further the prosecution and issuance of letter patents, copyright and other analogous protection thereon with the same legal force and effect as if executed by Executive. 
 6. Non-Competition. While Executive is employed at the Employer and for a period of two (2) years after termination of Executive’s employment (for any reason whatsoever, whether voluntary
or involuntarily), Executive will not, without the prior written approval of the Board, whether alone or as a partner, officer, director, consultant, agent, employee or stockholder of any company or other commercial enterprise, directly or
indirectly engage in any business or other activity in the United States or Canada which competes with the Employer in the field of therapeutic antibodies for cancer. The foregoing prohibition shall not prevent Executive’s employment or
engagement after termination of Executive’s employment by any company or business organization, as long as the activities of any such employment or engagement, in any capacity, do not involve work on matters related to the products being
developed, manufactured, or marketed by the Employer during Executive’s employment with the Employer. Executive shall be permitted to own securities of a public company not in excess of five percent of any class of such securities and to own
stock, partnership interests or other securities of any entity not in excess of five percent of any class of such securities and such ownership shall not be considered to be in competition with the Employer. 

  
 8 

 7. Non-Solicitation. While Executive is employed at the Employer and for a period of two
(2) years after termination of such employment (for any reason, whether voluntary or involuntarily), Executive agrees that Executive will not: 
 (a) directly or indirectly solicit, entice or induce any customer to become a customer of any other person, firm or corporation with respect to products then sold or under development by the Employer or
to cease doing business with the Employer, and Executive shall not approach any such person, firm or corporation for such purpose or authorize or knowingly approve the taking of such actions by any other person; or 

(b) directly or indirectly solicit or recruit any employee of the Employer to work for a third party other than the Employer (excluding
newspaper or similar print or electronic solicitations of general circulation). 
 8. General Provisions. 

(a) Executive acknowledges and agrees that the type and periods of restrictions imposed in Sections 4, 5, 6 and 7 of this Agreement are
fair and reasonable, and that such restrictions are intended solely to protect the legitimate interests of the Employer, rather than to prevent Executive from earning a livelihood. Executive recognizes that the Employer competes worldwide, and that
Executive’s access to Confidential Information makes it necessary for the Employer to restrict Executive’s post-employment activities in any market in which the Employer competes, and in which Executive’s access to Confidential
Information and other proprietary information could be used to the detriment of the Employer. In the event that any restriction set forth in this Agreement is determined to be overbroad with respect to scope, time or geographical coverage, Executive
agrees that such a restriction or restrictions should be modified and narrowed, either by a court or by the Employer, so as to preserve and protect the legitimate interests of the Employer as described in this Agreement, and without negating or
impairing any other restrictions or agreements set forth herein. 
 (b) Executive acknowledges and agrees that if Executive
should breach any of the covenants, restrictions and agreements contained herein, irreparable loss and injury would result to the Employer, and that damages arising out of such a breach may be difficult to ascertain. Executive therefore agrees that,
in addition to all other remedies provided at law or at equity, the Employer shall be entitled to have the covenants, restrictions and agreements contained in Sections 4, 5, 6, and 7 specifically enforced (including, without limitation, by
temporary, preliminary, and permanent injunctions and restraining orders) by any state or federal court in the State of New Jersey having equity jurisdiction and Executive agrees to subject Executive to the jurisdiction of such court. 

(c) Executive agrees that if the Employer fails to take action to remedy any breach by Executive of this Agreement or any portion of the
Agreement, such inaction by the Employer shall not operate or be construed as a waiver of any subsequent breach by Executive of the same or any other provision, agreement or covenant. 

(d) Executive acknowledges and agrees that the payments and benefits to be provided to Executive under this Agreement are provided as
consideration for the covenants in Sections 4, 5, 6, and 7 hereof. 
 9. Survivorship. The respective rights and obligations of the
parties under this Agreement shall survive any termination of Executive’s employment to the extent necessary to the intended preservation of such rights and obligations. 
 10. Mitigation. Executive shall not be required to mitigate the amount of any payment or benefit provided for in this Agreement by seeking other employment or otherwise and there shall be no offset
against amounts due Executive under this Agreement on account of any remuneration attributable to any subsequent employment that Executive may obtain. 
 11. Notices. All notices and other communications required or permitted under this Agreement or necessary or convenient in connection herewith shall be in writing and shall be deemed to have been
given when hand delivered or mailed by registered or certified mail, as follows (provided that notice of change of address shall be deemed given only when received): 
 If to the Company, to: 
 Immunomedics, Inc. 

300 American Road 

Morris Plains, NJ 07950 
 If to Executive, to: 
 Cynthia L. Sullivan 

Immunomedics, Inc. 
 300 American Road 
 Morris Plains, NJ 07950 

  
 9 

 or to such other names or addresses as the Company or Executive, as the case may be, shall designate by
notice to each other person entitled to receive notices in the manner specified in this Section. 
 12. Contents of Agreement: Amendment and
Assignment. 
 (a) This Agreement sets forth the entire understanding between the parties hereto with respect to the subject
matter hereof and supercedes any and all prior agreements, including the Prior Employment Agreement, and understandings concerning Executive’s employment by the Company and cannot be changed, modified, extended or terminated except upon written
amendment approved by the Board and executed on its behalf by a duly authorized officer and by Executive. 
 (b) All of the
terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the parties hereto, except that the
duties and responsibilities of Executive under this Agreement are of a personal nature and shall not be assignable or delegatable in whole or in part by Executive. The Company shall require any successor (whether direct or indirect, by purchase,
merger, consolidation, reorganization or otherwise) to all or substantially all of the business or assets of the Company, within 15 days of such succession, expressly to assume and agree to perform this Agreement in the same manner and to the same
extent as the Company would be required to perform if no such succession had taken place. 
 13. Severability. If any provision of this
Agreement or application thereof to anyone or under any circumstances is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which
can be given effect without the invalid or unenforceable provision or application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with
respect to particular circumstances, it shall nevertheless remain in full force and effect in all other circumstances. 
 14. Remedies
Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement
or now or hereafter existing at law or in equity. No delay or omission by a party in exercising any right, remedy or power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or
power may be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in its sole discretion. 
 15. Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments under this Agreement all federal, state and
local taxes as the Company is required to withhold pursuant to any law or governmental rule or regulation. Executive shall bear all expense of, and be solely responsible for, all federal, state and local taxes due with respect to any payment
received under this Agreement. 
 16. Miscellaneous. This Agreement may be executed in counterparts, each of which is an original. It
shall not be necessary in making proof of this Agreement or any counterpart hereof to produce or account for any of the other counterparts. 

17. Governing Law. This Agreement shall be governed by and interpreted under the laws of the State of New Jersey without giving effect to any
conflict of laws provisions or canons of construction that construe agreements against the draftsperson. 
 18. Section 409A of the
Code. This Agreement is intended to comply with section 409A of the Code and its corresponding regulations, to the extent applicable, and shall be so construed. Notwithstanding anything in this Agreement to the contrary, payments may only be
made under this Agreement upon an event and in a manner permitted by section 409A of the Code, to the extent applicable. For purposes of section 409A of the Code, all payments to be made upon the termination of the Executive’s employment under
this Agreement may only be made upon a “separation from service” under section 409A of the Code, each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this
Agreement is to be treated as a right to a series of separate payments. In no event shall Executive, directly or indirectly, designate the calendar year of payment. All reimbursements provided under this Agreement shall be made or provided in
accordance with Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement 

  
 10 

 
is for expenses incurred during the Term (or during such other time period specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not
affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is incurred, and
(iv) the right to reimbursement is not subject to liquidation or exchange for another benefit. Nothing herein shall be construed as having modified the time and form of payment of any amounts or payments of “deferred compensation”
within the meaning section 409A of the Code that were otherwise payable pursuant to the terms of any agreement between Company and the Executive in effect on or after January 1, 2005 and prior to the date of this Agreement. 

[Signature Page Follows] 

  
 11 

 IN WITNESS WHEREOF, the undersigned, intending to be legally bound, have executed this
Agreement as of the date first above written. 
  

			
	IMMUNOMEDICS, INC.
		
	By:	 	 /s/ Gerard G. Gorman

	Name:	 	Gerard G. Gorman
	Title:	 	Senior Vice President, Finance and Business Development, and Chief Financial Officer
	
	EXECUTIVE
	
	 /s/ Cynthia L. Sullivan

	Cynthia L. Sullivan

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]